In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell–Related Injury
Drug repurposing is a valuable strategy for rare diseases. Sickle cell disease (SCD) is a rare hereditary hemolytic anemia accompanied by acute and chronic painful episodes, most often in the context of vaso-occlusive crisis (VOC). Although progress in the knowledge of pathophysiology of SCD have al...
Shranjeno v:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2023-03-01
|
| Serija: | HemaSphere |
| Online dostop: | http://journals.lww.com/10.1097/HS9.0000000000000848 |
| Oznake: |
Brez oznak, prvi označite!
|
